EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Improving access to gut‐directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a “smart” solution?

Syed S Hasan, Sarah Ballou, Laurie Keefer, Dipesh H Vasant iD

Neurogastroenterology & Motility · 2023

DOI: 10.1111/nmo.14554 ↗

At a glance

Übersichtsarbeit in Neurogastroenterology & Motility, 2023. Written by Syed S Hasan and 3 co-authors. Institution: Neurogastroenterology Unit, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK. Major MEDLINE topics: Irritable Bowel Syndrome, Mobile Applications, Hypnosis. Cited 11 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Gut‐directed hypnotherapy (GDH) is a highly effective brain‐gut behavioral therapy which is recommended in international guidelines for the treatment of irritable bowel syndrome (IBS). There is increasing recognition of the value of GDH as part of integrated care alongside medical and dietary approaches. This has led to recent innovations to widen access to GDH to meet the increasing demand. Recent advances include streamlined courses of individualized GDH, group therapy, and remote delivery. In this issue of Neurogastroenterology and Motility , Peters et al. retrospectively report outcomes of smartphone app‐delivered GDH in a population with self‐reported IBS. While adherence was low, those that completed smart phone‐delivered GDH‐achieved symptom benefit. This mini‐review summarizes the current evidence‐base for available modalities of GDH and discusses the current and future utility and development of mobile health applications in the digital therapeutics' era.

Subjects

MeSH terms (MEDLINE)

Irritable Bowel SyndromeMobile ApplicationsHypnosisHumansRetrospective StudiesBrain

Author keywords

digital healthhypnotherapyirritable bowel syndrome

Authors and institutions

  • Neurogastroenterology Unit, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.
  • Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
  • Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • The Henry D. Janowitz Division of Gastroenterology, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID profiles: Dipesh H Vasant

Cite

APA

Hasan, S. S., Ballou, S., Keefer, L., & Vasant, D. H. (2023). Improving access to gut‐directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a “smart” solution?. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14554

Vancouver

Hasan SS, Ballou S, Keefer L, Vasant DH. Improving access to gut‐directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a “smart” solution?. Neurogastroenterology & Motility. 2023. doi:10.1111/nmo.14554

BibTeX
@article{Hasan2023,
  author = {Hasan, Syed S and Ballou, Sarah and Keefer, Laurie and Vasant, Dipesh H},
  title = {Improving access to gut‐directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a “smart” solution?},
  journal = {Neurogastroenterology & Motility},
  year = {2023},
  doi = {10.1111/nmo.14554}
}
Start for free →